@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP742203.RAfd1VkNxlkgC9kv6Foc05cEaLspRgbDd6CEiSVEWHeU4130_head { this: np:hasAssertion dgn-np:NP742203.RAfd1VkNxlkgC9kv6Foc05cEaLspRgbDd6CEiSVEWHeU4130_assertion; np:hasProvenance dgn-np:NP742203.RAfd1VkNxlkgC9kv6Foc05cEaLspRgbDd6CEiSVEWHeU4130_provenance; np:hasPublicationInfo dgn-np:NP742203.RAfd1VkNxlkgC9kv6Foc05cEaLspRgbDd6CEiSVEWHeU4130_publicationInfo; a np:Nanopublication . dgn-np:NP742203.RAfd1VkNxlkgC9kv6Foc05cEaLspRgbDd6CEiSVEWHeU4130_assertion a np:Assertion . dgn-np:NP742203.RAfd1VkNxlkgC9kv6Foc05cEaLspRgbDd6CEiSVEWHeU4130_provenance a np:Provenance . dgn-np:NP742203.RAfd1VkNxlkgC9kv6Foc05cEaLspRgbDd6CEiSVEWHeU4130_publicationInfo a np:PublicationInfo . } dgn-np:NP742203.RAfd1VkNxlkgC9kv6Foc05cEaLspRgbDd6CEiSVEWHeU4130_assertion { miriam-gene:983 a ncit:C16612 . lld:C1140680 a ncit:C7057 . dgn-gda:DGNa40cabaa429fc7e3bfef208f32bb8eb2 sio:SIO_000628 miriam-gene:983, lld:C1140680; a sio:SIO_001121 . } dgn-np:NP742203.RAfd1VkNxlkgC9kv6Foc05cEaLspRgbDd6CEiSVEWHeU4130_provenance { dgn-np:NP742203.RAfd1VkNxlkgC9kv6Foc05cEaLspRgbDd6CEiSVEWHeU4130_assertion dcterms:description "[OSU-HDAC42, (i) unlike most HDACIs, elicited a more than five-fold increase in G(2)-phase cells, at 2.5 microM, with G(2) arrest followed by apoptosis; (ii) at 1.0 microM, completely repressed messenger RNA expression of the cell cycle progression gene cdc2; (iii) at low doses (0.25-1.0 microM for 24 hours), induced tumor cell epithelial differentiation, as evidenced by morphology changes and a more than five-fold up-regulation of epithelium-specific cytokeratins; (iv) potently abrogated the growth of numerous ovarian cancer cells, with IC(50) values of 0.5 to 1.0 microM, whereas also remaining eight-fold less toxic (IC(50) of 8.6 microM) to normal ovarian surface epithelial cells; and (v) chemosensitizated platinum-resistant mouse xenografts to cisplatin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:19484144; prov:wasDerivedFrom dgn-void:befree-2016; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-2016 pav:importedOn "2016-02-19"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP742203.RAfd1VkNxlkgC9kv6Foc05cEaLspRgbDd6CEiSVEWHeU4130_publicationInfo { this: dcterms:created "2016-05-13T12:47:21+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v4.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v4.0.0" . }